Inhaled corticosteroids in COPD and the risk of serious pneumonia.
about
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseThe use of inhaled corticosteroids in pediatric asthma: updateThe asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?Exacerbations of COPDA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseUmeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a reviewDo inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic reviewAppropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawalAdvances in understanding COPDCardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effectRisk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisRates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-upSystemic effects of inhaled corticosteroids: an overview.Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers.Chronic obstructive pulmonary disease severity is associated with severe pneumonia.Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPDComparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort StudyThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practiceGFF MDI for the improvement of lung function in COPD - A look at the PINNACLE-1 and PINNACLE-2 data and beyond.Budesonide and fluticasone propionate differentially affect the airway epithelial barrierEffect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD.The risk and outcomes of pneumonia in patients on inhaled corticosteroids.Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a studyFirst maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
P2860
Q24197989-CDC0092C-5BE2-42C2-8FEB-D275E68EE577Q26739763-5D4522BB-9F8B-4CDF-B930-344D67111FDFQ26745760-F8C89744-0A89-4A0A-A2D1-E3E271670332Q26764891-161A0560-6FE9-4096-949B-675619398208Q26801661-12386126-A1DF-4744-AF3C-C9B8ED35B364Q27015685-AA1DCC97-98D9-4820-932B-957E4689BA13Q28069762-8D12783C-68CA-493D-9D4A-BFF1C9DCD4A3Q28074169-BEEA2494-F21F-456A-BF2A-FD443C4A4798Q28074701-ABF442B9-5066-4E89-A4DB-228C1505C6E7Q28596651-9A08C944-E744-4685-8ADB-68292CA5131CQ30390674-BB1DACFC-1931-4FBC-AD4A-26318B31D072Q33689926-250AB15E-7EF5-41A2-9BD2-7433904DDF3BQ33705358-498340CA-C274-4FD9-A3CA-ECDE2C158295Q33709357-BAF5FA0D-253E-4684-AE22-568A81C2E354Q33803143-3C124FFA-DB00-4AAE-B42A-ECBC24324AB2Q34007433-621F9344-74F2-4080-A3C0-9784BE74E007Q34065276-6243294F-2BA8-4604-98E7-98DAB7D65F22Q34287563-7A7F8ADB-6A90-4FCE-9403-4B638539E3F2Q34551086-564F2AE9-9582-46C9-BFCB-70FF53A11858Q35008414-4411F079-6812-45EF-80C8-773E8C4EA477Q35056155-14A02471-624C-4158-81CC-D5A0F9292284Q35088162-43CED8B9-B6CD-4C56-8385-91509A0CE0BDQ35222192-C230150B-23A5-412A-BCA7-D66CC43489A3Q35492192-0F204BFB-64D8-4B0C-BFCB-BA278AC765B9Q35538141-6E1ABD94-BFB3-47C3-B9CF-51A822686A62Q35538249-A1CD9FBD-E032-44A6-B91E-AD8F2BC83C25Q36141290-3FF2E021-9176-4D80-A858-912051BFE62DQ36206896-A2385162-1392-4B98-9689-EC0ECE6960F5Q36208427-3C58FF04-1EAB-48C1-82B5-D00B04F1C9BDQ36332206-D2A855D0-4E89-4102-A929-A160CD8B0E3DQ36356295-FEB3A06C-9514-4358-94D6-E7BC88839540Q36439199-59DEFFF3-8652-49DD-AE3B-BAD87A402481Q37042441-01E51C3F-09A5-4080-B22A-E198A9A83487Q37128138-9BF77C66-F450-4B72-BA52-DDAD159AA838Q37259422-3C6E6D17-BCA6-4175-81FA-7A0113DB9817Q37364624-A53AE2C4-5071-4D32-8E42-BAB4FAA358ADQ37371731-70B59D0A-B31D-409E-A10D-6DF9ED383C69Q37390146-9C16C493-9078-424C-99BF-632B1F8812D6Q37412962-3AF98E6B-452B-42CD-819C-00007622702BQ37446910-96FD56F6-1C10-41AA-B6A6-69E3D62C9933
P2860
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@en
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@nl
type
label
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@en
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@nl
prefLabel
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@en
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@nl
P2093
P2860
P1433
P1476
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
@en
P2093
Francesco Lapi
Pierre Ernst
Samy Suissa
Valérie Patenaude
P2860
P304
P356
10.1136/THORAXJNL-2012-202872
P407
P577
2013-11-01T00:00:00Z